0
Business
Trump Accelerates Psychedelic Research With $50 Million Ibogaine Commitment
April 18, 2026
Scroll
Posted 6 hours ago by
On Saturday, President Donald Trump signed an executive order directing the U.S. Food and Drug Administration to move faster on reviews tied to psychedelic-based research and treatment, including ibogaine that veteran advocates say may help post-traumatic stress disorder. Importance Rank: 1 read more
Benzinga
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: center
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.